Veterinary medicines: highlights of 2017
18 medicines recommended for marketing authorisation, including ten vaccines
The European Medicines Agency (EMA) has published an overview of its key recommendations of 2017, including for marketing authorisations of new veterinary medicines.
In 2017, EMA recommended 18 medicines for marketing authorisation, an increase of more than 60% compared to 2016. Of these, seven had a new active substance. Ten are vaccines, double the number of vaccines authorised in the previous year.
A selection of these recommendations can be found in the document published today.